SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Halozyme Therapeutics and Baxter International Inc. announced that the United States Food and Drug Administration approved Baxter’s subcutaneous treatment, HYQVIA, for adult patients with primary immunodeficiency.
ResMed, a San Diego-based company that develops medical devices for sleep apnea and other sleep-related breathing disorders, announced that its AirView compliance management is now connected to Fairview Health Services' Epic EHR system, enabling up to date delivery of sleep apnea patient data for use by the medical staff of Fairview, a network of hospitals and clinics throughout Minnesota.
The U.S. Food and Drug Administration announced that it approved a weight-loss drug developed by La Jolla-based Orexigen Therapeutics Inc.
MabVax Therapeutics Holdings Inc., a clinical stage oncology drug development company, announced that it has entered into agreements with Memorial Sloan Kettering Cancer Center and Juno Therapeutics for the development of therapeutic products using antibody targeting sequences derived from the fully-human antibodies discovered using the MabVax antibody discovery platform.
The J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, announced today that they have hired Nicole DeBerg as chief operating officer.
San Diego-based Aethlon Medical Inc. and its diagnostic subsidiary, Exosome Sciences Inc. announced that their researchers have developed and initially validated a diagnostic platform that could identify the presence of cancer in analyzed blood samples.
San Diego-based Astute Medical Inc. today announced that it has received clearance from the Food and Drug Administration to commence sales of its first biomarker-based immunoassay, NephroCheck.
San Diego--based ResMed Inc. and APEX Medical Corp. have agreed to a confidential settlement resolving their outstanding patent disputes.
Biotech: The Device Is a Less Expensive Solution For Incurable Skin Disorders
Martyn Gross has suffered from psoriasis for most of his life, particularly on the difficult-to-treat regions of the hand and feet. After years of trying costly and ineffective treatments from uncomfortable phototherapy sessions in cold medical facilities to topical creams that wash off too easily, Gross decided to develop a handheld light therapy device to treat himself at home.
HEALTH: Sequencing and Analytics Part of Process
Recent trends in biotech research point to faster, more efficient and less costly drug development for pharmaceutical companies.
San Diego-based Ajinomoto Althea Inc., a biopharmaceutical contract development and manufacturing company, has received clearance to test its commercial drug products for the European market.
Mirati Therapeutics Inc. announced that the first patient has been dosed in its phase one clinical study for the treatment of patients with advanced solid tumors.
Halozyme Therapeutics Inc. announced that the Food and Drug Administration has granted Fast Track designation for its program investigating a treatment for patients with metastatic pancreatic cancer.
RuiYi Inc. announced today the appointment of Mark Saad as chief financial officer.